These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 8666811

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS.
    Bussolati B, David S, Cambi V, Tobias PS, Camussi G.
    Int J Mol Med; 2002 Oct; 10(4):441-9. PubMed ID: 12239591
    [Abstract] [Full Text] [Related]

  • 23. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
    Figueiredo MD, Salter CE, Hurley DJ, Moore JN.
    Vet Immunol Immunopathol; 2008 Feb 15; 121(3-4):275-80. PubMed ID: 18023485
    [Abstract] [Full Text] [Related]

  • 24. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
    Wurfel MM, Wright SD.
    Prog Clin Biol Res; 1995 Feb 15; 392():287-95. PubMed ID: 8524933
    [Abstract] [Full Text] [Related]

  • 25. Dual effects of soluble CD14 on LPS priming of neutrophils.
    Troelstra A, Giepmans BN, Van Kessel KP, Lichenstein HS, Verhoef J, Van Strijp JA.
    J Leukoc Biol; 1997 Feb 15; 61(2):173-8. PubMed ID: 9021923
    [Abstract] [Full Text] [Related]

  • 26. The molecular basis for therapeutic concepts utilizing CD14.
    Stelter F, Bernheiden M, Menzel R, Witt S, Jack RS, Grunwald U, Fan X, Schütt C.
    Prog Clin Biol Res; 1998 Feb 15; 397():301-13. PubMed ID: 9575571
    [Abstract] [Full Text] [Related]

  • 27. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins.
    Kitchens RL, Thompson PA.
    J Endotoxin Res; 2003 Feb 15; 9(2):113-8. PubMed ID: 12803885
    [Abstract] [Full Text] [Related]

  • 28. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
    Theofan G, Horwitz AH, Williams RE, Liu PS, Chan I, Birr C, Carroll SF, Mészáros K, Parent JB, Kasler H.
    J Immunol; 1994 Apr 01; 152(7):3623-9. PubMed ID: 7511654
    [Abstract] [Full Text] [Related]

  • 29. Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14.
    Pugin J, Ulevitch RJ, Tobias PS.
    Prog Clin Biol Res; 1995 Apr 01; 392():369-73. PubMed ID: 8524944
    [Abstract] [Full Text] [Related]

  • 30. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR, Lamping N, Hoess A.
    J Immunol; 1997 Dec 01; 159(11):5599-605. PubMed ID: 9548502
    [Abstract] [Full Text] [Related]

  • 31. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ, van der Tol ME, Van Kessel KP, Verhoef J, Van Strijp JA.
    J Immunol; 1998 Oct 01; 161(7):3607-15. PubMed ID: 9759883
    [Abstract] [Full Text] [Related]

  • 32. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein.
    Tsutsumi-Ishii Y, Shimada K, Daida H, Toman R, Nagaoka I.
    Int Immunol; 2008 Feb 01; 20(2):199-208. PubMed ID: 18056918
    [Abstract] [Full Text] [Related]

  • 33. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome.
    Martin TR, Rubenfeld GD, Ruzinski JT, Goodman RB, Steinberg KP, Leturcq DJ, Moriarty AM, Raghu G, Baughman RP, Hudson LD.
    Am J Respir Crit Care Med; 1997 Mar 01; 155(3):937-44. PubMed ID: 9117029
    [Abstract] [Full Text] [Related]

  • 34. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
    Blais DR, Vascotto SG, Griffith M, Altosaar I.
    Invest Ophthalmol Vis Sci; 2005 Nov 01; 46(11):4235-44. PubMed ID: 16249503
    [Abstract] [Full Text] [Related]

  • 35. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation.
    Tobias PS, Ulevitch RJ.
    Immunobiology; 1993 Apr 01; 187(3-5):227-32. PubMed ID: 7687234
    [Abstract] [Full Text] [Related]

  • 36. Regulation of interactions of endotoxin with host cells.
    Gioannini TL, Teghanemt A, Zarember KA, Weiss JP.
    J Endotoxin Res; 2003 Apr 01; 9(6):401-8. PubMed ID: 14733729
    [Abstract] [Full Text] [Related]

  • 37. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
    Stamme C, Müller M, Hamann L, Gutsmann T, Seydel U.
    Am J Respir Cell Mol Biol; 2002 Sep 01; 27(3):353-60. PubMed ID: 12204898
    [Abstract] [Full Text] [Related]

  • 38. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria.
    Lengacher S, Jongeneel CV, Le Roy D, Lee JD, Kravchenko V, Ulevitch RJ, Glauser MP, Heumann D.
    J Inflamm; 2002 Sep 01; 47(4):165-72. PubMed ID: 9144073
    [Abstract] [Full Text] [Related]

  • 39. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
    Ren L, Leung WK, Loo TW, Jin L.
    J Periodontal Res; 2005 Oct 01; 40(5):407-16. PubMed ID: 16105094
    [Abstract] [Full Text] [Related]

  • 40. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
    Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD.
    J Exp Med; 1994 Jan 01; 179(1):269-77. PubMed ID: 7505800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.